TAPBPR employs a ligand-independent docking mechanism to chaperone MR1 molecules.
McShan AC, Devlin CA, Papadaki GF, Sun Y, Green AI, Morozov GI, Burslem GM, Procko E, Sgourakis NG
Nat Chem Biol. 2022 Jun 20. pii: 10.1038/s41589-022-01049-9. doi: 10.1038/s41589-022-01049-9.
(Link opens in a new window)
PubMed
(Link opens in a new window)
Article